ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2343

$1.26M Total Retail Price of All Prescriptions

Rank: 48 out of 2343

1,055 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,055 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 1,055 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 24,393 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 1,270 1,133 1 2
LISINOPRIL 1,065 923 2 3
SIMVASTATIN 992 861 3 1
AMLODIPINE BESYLATE 973 907 4 5
METOPROLOL TARTRATE 969 845 5 7
HYDROCODONE-ACETAMINOPHEN 952 693 S3 6 13
OMEPRAZOLE 905 716 7 4
FUROSEMIDE 899 811 8 6
PRAVASTATIN SODIUM 651 550 9 15
ATENOLOL 588 558 10 12
WARFARIN SODIUM 563 499 11 8
POTASSIUM CHLORIDE 554 504 12 18
ATORVASTATIN CALCIUM 476 404 13 10
GLYBURIDE 422 375 R 14 62
CITALOPRAM HBR 410 340 15 17
METFORMIN HCL 380 280 16 9
HYDROCHLOROTHIAZIDE 378 361 17 11
AZITHROMYCIN 373 297 18 39
GABAPENTIN 335 289 19 16
CARVEDILOL 289 252 20 27
KLOR-CON M20 264 238 21 44
QUINAPRIL HCL 254 225 22 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 253 205 23 42
PANTOPRAZOLE SODIUM 252 229 24 22
DONEPEZIL HCL 243 228 25 21
LOSARTAN POTASSIUM 239 214 26 19
CLOPIDOGREL 232 218 27 26
PAROXETINE HCL 228 207 28 66
GLIMEPIRIDE 221 206 29 45
SERTRALINE HCL 212 164 30 20
DIGOXIN 210 205 31 35
TRIAMTERENE-HCTZ 207 198 32 57
CIPROFLOXACIN HCL 189 164 33 72
ALLOPURINOL 185 179 34 31
PLAVIX 183 176 35 38
VERAPAMIL ER 181 159 36 95
NEXIUM 177 158 37 33
DOXAZOSIN MESYLATE 175 149 38 98
CRESTOR 172 154 39 30
ISOSORBIDE MONONITRATE ER 169 141 40 32
LANTUS SOLOSTAR 169 137 40 101
LOSARTAN-HYDROCHLOROTHIAZIDE 165 143 42 64
ZOLPIDEM TARTRATE 154 109 43 24
LANTUS 152 102 44 51
METOPROLOL SUCCINATE 145 142 45 14
LANSOPRAZOLE 142 122 46 162
SYNTHROID 136 134 47 40
ZETIA 135 124 48 52
KLOR-CON M10 134 121 49 107
TRAMADOL HCL 133 111 50 25
HYDRALAZINE HCL 130 130 51 92
PREDNISONE 127 107 52 37
GLIPIZIDE 127 104 52 56
JANUVIA 118 106 54 50
INSULIN SYRINGE 117 92 55 102
DIOVAN 115 108 56 23
NIFEDIPINE ER 114 114 57 89
KLOR-CON 8 110 110 58 226
MELOXICAM 108 89 59 68
BISOPROLOL-HYDROCHLOROTHIAZIDE 107 104 60 151
AMITRIPTYLINE HCL 107 69 R 60 117
METHYLPREDNISOLONE 107 89 60 122
DILTIAZEM 24HR ER 104 80 63 76
PROPRANOLOL HCL 104 104 63 132
RANITIDINE HCL 103 91 65 43
MECLIZINE HCL 103 101 65 103
BENICAR 103 87 65 93
OXYCODONE-ACETAMINOPHEN 102 96 S2 68 49
ENALAPRIL MALEATE 101 89 69 58
BUSPIRONE HCL 100 79 70 146
TAMSULOSIN HCL 100 93 70 29
CLONIDINE HCL 99 81 72 70
CLOTRIMAZOLE-BETAMETHASONE 95 74 73 127
LOVASTATIN 93 62 74 47
ALENDRONATE SODIUM 93 64 74 28
PRAMIPEXOLE DIHYDROCHLORIDE 90 87 76 187
FAMOTIDINE 88 55 77 60
BENICAR HCT 87 80 78 156
NAMENDA 85 85 79 36
AMLODIPINE BESYLATE-BENAZEPRIL 83 70 80 59
ESCITALOPRAM OXALATE 80 58 81 55
POLYETHYLENE GLYCOL 3350 77 74 82 54
PRADAXA 76 74 83 188
AMOXICILLIN 75 49 84 118
TRIAMCINOLONE ACETONIDE 74 70 85 137
CEFADROXIL 73 60 86 451
OXYCODONE HCL 72 45 S2 87 67
CELEBREX 72 71 87 71
ACETAMINOPHEN-CODEINE 71 54 S3 89 112
IBUPROFEN 71 52 89 75
SPIRIVA 70 48 91 48
DILTIAZEM ER 67 58 92 207
GLIPIZIDE XL 66 58 93 84
FLUOXETINE HCL 66 47 93 82
FLUTICASONE PROPIONATE 64 45 95 46
ACTOS 64 64 95 125
BUMETANIDE 64 37 95 91
TERAZOSIN HCL 64 44 95 143
ADVAIR DISKUS 64 33 95 34
PROAIR HFA 63 38 100 86
VENTOLIN HFA 63 39 100 79
IRBESARTAN 63 54 100 270
SPIRONOLACTONE 62 42 103 65
NIFEDICAL XL 62 52 103 148
KLOR-CON 10 61 61 105 134
NITROSTAT 61 46 105 164
SINGULAIR 58 36 107 100
ATENOLOL-CHLORTHALIDONE 58 58 107 190
FINASTERIDE 55 50 109 80
TRICOR 55 55 109 96
OXYCONTIN 55 42 S2 109 138
PROCHLORPERAZINE MALEATE 54 48 112 287
FENTANYL 53 41 S2 113 69
METOCLOPRAMIDE HCL 53 39 113 168
PEN NEEDLE 51 38 115 119
LORATADINE 51 42 115 289
MICARDIS 51 51 115 363
AMILORIDE-HYDROCHLOROTHIAZIDE 50 47 118 391
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.